Literature DB >> 3143745

Influence of natural and recombinant interleukin 2 on endothelial cell arachidonate metabolism. Induction of de novo synthesis of prostaglandin H synthase.

K Frasier-Scott1, H Hatzakis, D Seong, C M Jones, K K Wu.   

Abstract

We studied the effects of natural and recombinant human IL-2 (rIL-2) on secretion of prostacyclin (PGI2), vWf, and tissue-type plasminogen activator (tPA). IL-2 elicited a steady increase in PGI2 synthesis by cultured human umbilical vein endothelial cells (HUVECS) and bovine aortic endothelial cells but had no effect on vWf or tPA. Both purified natural IL-2 (nIL-2) and rIL-2 induced significant PGI2 synthesis. Substitution of the cysteine residue at position 125 of rIL-2 with serine or alanine led to loss of PGI2-stimulatory activity in HUVECS without affecting thymidine incorporation in lymphocytes. HPLC analysis of arachidonate metabolites detected predominantly 6 keto-PGF1 alpha (6KPGF1 alpha) peak. Treatment of cultured endothelial cells with cycloheximide and actinomycin D resulted in inhibition of 6KPGF1 alpha synthesis. The Western blot using a polyclonal antibody against PGH synthase revealed an increment in the 70-kD subunit of PGH synthase by nIL-2 and rIL-2, but not by alanine-substituted rIL-2. We conclude that IL-2 stimulated sustained PGI2 production by a mechanism that includes the de novo synthesis of PGH synthase. This mechanism for regulating AA metabolism probably has important physiologic implications.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3143745      PMCID: PMC442767          DOI: 10.1172/JCI113805

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  28 in total

1.  Functional and morphologic characterization of human T cells continuously grown in vitro.

Authors:  F W Ruscetti; D A Morgan; R C Gallo
Journal:  J Immunol       Date:  1977-07       Impact factor: 5.422

2.  Continuous culture of T cells cytotoxic for autologous human leukaemia cells.

Authors:  J M Zarling; F H Bach
Journal:  Nature       Date:  1979-08-23       Impact factor: 49.962

3.  Selective in vitro growth of T lymphocytes from normal human bone marrows.

Authors:  D A Morgan; F W Ruscetti; R Gallo
Journal:  Science       Date:  1976-09-10       Impact factor: 47.728

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  T cell growth factor: parameters of production and a quantitative microassay for activity.

Authors:  S Gillis; M M Ferm; W Ou; K A Smith
Journal:  J Immunol       Date:  1978-06       Impact factor: 5.422

6.  Mechanism for irreversible self-deactivation of prostaglandin synthetase.

Authors:  R W Egan; J Paxton; F A Kuehl
Journal:  J Biol Chem       Date:  1976-12-10       Impact factor: 5.157

7.  Culture of arterial endothelial cells: characterization and growth of bovine aortic cells.

Authors:  F M Booyse; B J Sedlak; M E Rafelson
Journal:  Thromb Diath Haemorrh       Date:  1975-12-15

8.  Interaction between lymphocytes and platelets in the synthesis of prostacyclin.

Authors:  K K Wu; A C Papp; C E Manner; E R Hall
Journal:  J Clin Invest       Date:  1987-06       Impact factor: 14.808

9.  Peroxidase-dependent deactivation of prostacyclin synthetase.

Authors:  E A Ham; R W Egan; D D Soderman; P H Gale; F A Kuehl
Journal:  J Biol Chem       Date:  1979-04-10       Impact factor: 5.157

10.  Human vascular endothelial cells in culture. Growth and DNA synthesis.

Authors:  M A Gimbrone; R S Cotran; J Folkman
Journal:  J Cell Biol       Date:  1974-03       Impact factor: 10.539

View more
  14 in total

1.  cDNA cloning and functional activity of a glucocorticoid-regulated inflammatory cyclooxygenase.

Authors:  M K O'Banion; V D Winn; D A Young
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-01       Impact factor: 11.205

2.  Primed stimulation of isolated perfused rabbit lung by endotoxin and platelet activating factor induces enhanced production of thromboxane and lung injury.

Authors:  W L Salzer; C E McCall
Journal:  J Clin Invest       Date:  1990-04       Impact factor: 14.808

3.  Effect of recombinant human interleukin 2 on neutrophil adherence to endothelial cells in vitro.

Authors:  J Li; S Gyorffy; S Lee; C S Kwok
Journal:  Inflammation       Date:  1996-08       Impact factor: 4.092

Review 4.  Lymphokine activated killer cells.

Authors:  A Lindemann; F Herrmann; W Oster; R Mertelsmann
Journal:  Blut       Date:  1989-10

Review 5.  Role of gamma delta T cells in immunity to infectious diseases and the regulation of hematolymphoid cell development.

Authors:  S R Carding
Journal:  Immunol Res       Date:  1998       Impact factor: 2.829

6.  Interferon-alpha and interleukin 2 synergistically enhance basic fibroblast growth factor synthesis and induce release, promoting endothelial cell growth.

Authors:  F Cozzolino; M Torcia; M Lucibello; L Morbidelli; M Ziche; J Platt; S Fabiani; J Brett; D Stern
Journal:  J Clin Invest       Date:  1993-06       Impact factor: 14.808

7.  Nitric oxide synthase responsible for L-arginine-induced relaxation of rat aortic rings in vitro may be an inducible type.

Authors:  H Moritoki; S Takeuchi; T Hisayama; W Kondoh
Journal:  Br J Pharmacol       Date:  1992-10       Impact factor: 8.739

8.  Human interleukin-1 induces a rapid relaxation of the rabbit isolated mesenteric artery.

Authors:  F Marceau; E Petitclerc; D DeBlois; P Pradelles; P E Poubelle
Journal:  Br J Pharmacol       Date:  1991-06       Impact factor: 8.739

9.  Aspirin inhibits interleukin 1-induced prostaglandin H synthase expression in cultured endothelial cells.

Authors:  K K Wu; R Sanduja; A L Tsai; B Ferhanoglu; D S Loose-Mitchell
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-15       Impact factor: 11.205

10.  Interleukin-2 induces early multisystem organ edema mediated by neutrophils.

Authors:  R Welbourn; G Goldman; L Kobzik; I Paterson; D Shepro; H B Hechtman
Journal:  Ann Surg       Date:  1991-08       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.